BRIEF-GSK receives US approval for diabetes treatment Tanzeum By: Reuters: Company News April 15, 2014 at 13:06 PM EDT * GSK receives US approval for once-weekly type 2 diabetes treatment, Tanzeum Tm (Albiglutide) Read More >> Related Stocks: Gsk Plc ADR